Hepatitis B screening proposed for all high-risk adults

February 11, 2014
Hepatitis B screening proposed for all high-risk adults
Nearly 1 million in U.S. are infected, says Preventive Services Task Force.

(HealthDay)—Adults at high risk for hepatitis B should be screened for the viral infection, according to a draft recommendation from the U.S. Preventive Services Task Force.

Although most people born in the United States are vaccinated against hepatitis B, there are still nearly 1 million infected people in the United States. Of those with B infection, 15 percent to 25 percent die from serious liver disease or liver cancer.

"The good news is that evidence shows we can catch the disease early in many people who are already infected by screening for hepatitis B virus infection in persons at high risk for infection," member Dr. Douglas Owens, a professor of medicine at Stanford University, said in a task force news release. "And treatment can help prevent in people who have chronic hepatitis B infection."

Screening consists of a blood test.

Based on a review of existing evidence, the task force concluded the following people should be screened for hepatitis B:

  • Anyone born in countries or regions with a high rate of hepatitis B infection, including Africa, Southeast Asia, the Middle East, Eastern Europe and the northern countries in South America
  • People born in the United States who were not vaccinated against hepatitis B in infancy whose parents were born in areas with a high rate of hepatitis B infection
  • Those who are HIV-positive
  • IV drug users
  • Gay and bisexual men
  • People with a weak immune system
  • Those undergoing treatment for kidney failure

Vaccination remains the best way to prevent hepatitis B infection, the panel pointed out.

"The United States has universal vaccination of all infants at birth, catch-up vaccination of adolescents and vaccination of groups. Fortunately, most people in the U.S. are no longer at risk of getting hepatitis B," task force member Dr. Mark Ebell said in the news release.

"Because some countries have high rates of [hepatitis B] infection, it is important for immigrants from those countries and their doctors to be aware of their risk status and screen them if appropriate," he added.

Public comments on this draft proposal are being accepted until March 11. The task force—an independent, advisory group of health care experts—will consider these comments in developing its final statement.

Explore further: Screen all baby boomers for hepatitis C, expert panel says

More information: The World Health Organization provides more information on hepatitis B.

Evidence Report
Draft Recommendation
Comment on Recommendation

Related Stories

Screen all baby boomers for hepatitis C, expert panel says

June 24, 2013
(HealthDay)—All adults born between 1945 and 1965—the baby boom generation—should be screened for the hepatitis C virus along with injection-drug users and anyone transfused before 1992, according to new recommendations ...

U.S. task force: Baby boomers should be tested for hepatitis C

November 26, 2012
(HealthDay)—A U.S. task force suggests that people at high risk for the hepatitis C virus should be screened, which includes those with a history of intravenous drug use and those who received blood transfusions before ...

New test IDs genotype of hepatitis C

June 20, 2013
(HealthDay)—A new test to help doctors identify the genotype of a person's hepatitis C infection has been approved by the U.S. Food and Drug Administration.

Follow-up lacking for babies after hepatitis B vaccination: CDC

September 27, 2012
(HealthDay)—Many U.S. babies born to mothers infected with hepatitis B do not receive recommended follow-up testing after vaccination, a new study finds.

Baby boomers need hepatitis C test, CDC study confirms

August 15, 2013
(HealthDay)—Baby boomers—the generation known for sex, drugs and rock and roll—are the most likely Americans to develop hepatitis C, and too many of them aren't tested until it's too late to prevent liver damage, U.S. ...

HIV sufferers need hepatitis safeguards

March 27, 2013
Stronger protections are needed to prevent people with HIV from also becoming infected with hepatitis, researchers argue in a new study led by Michigan State University.

Recommended for you

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.